Clinical trial
Optimal Dose of Proton Pump Inhibitors Following an Upper Gastrointestinal Bleed
NCT02235311 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimal Dose of Proton Pump Inhibitors Following an Upper Gastrointestinal Bleed
- Lead sponsor
- University of Missouri-Columbia
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 31, 2014
- Completion date
- August 17, 2015
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
upper gastrointestinal bleed